Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues
eLife · 2023
DOI: 10.7554/elife.85773 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Briana M Bohannon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Miller School of Medicine, University of Miami, Miami, United States. Hauptthemen laut MEDLINE: Potassium Channels, Voltage-Gated, Long QT Syndrome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Voltage-gated potassium (K V ) channels are important regulators of cellular excitability and control action potential repolarization in the heart and brain. K V channel mutations lead to disordered cellular excitability. Loss-of-function mutations, for example, result in membrane hyperexcitability, a characteristic of epilepsy and cardiac arrhythmias. Interventions intended to restore K V channel function have strong therapeutic potential in such disorders. Polyunsaturated fatty acids (PUFAs) and PUFA analogues comprise a class of K V channel activators with potential applications in the treatment of arrhythmogenic disorders such as long QT syndrome (LQTS). LQTS is caused by a loss-of-function of the cardiac I Ks channel – a tetrameric potassium channel complex formed by K V 7.1 and associated KCNE1 protein subunits. We have discovered a set of aromatic PUFA analogues that produce robust activation of the cardiac I Ks channel, and a unique feature of these PUFA analogues is an aromatic, tyrosine head group. We determine the mechanisms through which tyrosine PUFA analogues exert strong activating effects on the I Ks channel by generating modified aromatic head groups designed to probe cation–pi interactions, hydrogen bonding, and ionic interactions. We found that tyrosine PUFA analogues do not activate the I Ks channel through cation–pi interactions, but instead do so through a combination of hydrogen bonding and ionic interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, Miller School of Medicine, University of Miami, Miami, United States.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Biological Sciences and Centre for Molecular Simulation, University of Calgary, Calgary, Canada.
ORCID-Profile: D Peter Tieleman, Sara I Liin, H Peter Larsson
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
- NIH HHS
- HORIZON EUROPE European Research Council
- Swedish Research Council
- National Institutes of Health
Zitieren
APA
Bohannon, B. M., Jowais, J. J., Nyberg, L., Olivier-Meo, V., Corradi, V., Tieleman, D. P., Liin, S. I., & Larsson, H. P. (2023). Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues. eLife. https://doi.org/10.7554/elife.85773
Vancouver
Bohannon BM, Jowais JJ, Nyberg L, Olivier-Meo V, Corradi V, Tieleman DP, et al. Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues. eLife. 2023. doi:10.7554/elife.85773
BibTeX
@article{Bohannon2023,
author = {Bohannon, Briana M and Jowais, Jessica J and Nyberg, Leif and Olivier-Meo, Vanessa and Corradi, Valentina and Tieleman, D Peter and Liin, Sara I and Larsson, H Peter},
title = {Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.85773}
}
EUVIMED